Showing results (21-30 of 166) with videos related to
Sort By:
Pageof 17
BMC Infectious Diseases|April 27, 2013
Limits of patient isolation measures to control extended-spectrum beta-lactamase-producing Enterobacteriaceae: model-based analysis of clinical data in a pediatric wardMatthieu Domenech de Cellès, Jean-Ralph Zahar, Véronique Abadie, et al.Critical Care (London, England)|June 29, 2017
Treatment of severe hospital-acquired and ventilator-associated pneumonia: a systematic review of inclusion and judgment criteria used in randomized controlled trialsEmmanuel Weiss, Wafa Essaied, Christophe Adrie, et al.Diagnostic Microbiology and Infectious Disease|December 23, 2019
Impact of freeze/thaw cycles and single freezing at -80 °C on the viability of aerobic bacteria from rectal swabs performed with the ESwabTM systemRindala Saliba, Jean Ralph Zahar, Fatma El Allaoui, et al.Annals of Intensive Care|November 12, 2017
Piperacillin-tazobactam as alternative to carbapenems for ICU patientsBenoit Pilmis, Vincent Jullien, Alexis Tabah, et al.Expert Opinion on Pharmacotherapy|November 25, 2024
Improving pharmacokinetic/pharmacodynamic outcomes of antimicrobial therapy for pneumonia in the ICUMichael Thy, Sophie Magréault, Jean-Ralph Zahar, et al.Nature Communications|January 12, 2022
Rapid antigen testing as a reactive response to surges in nosocomial SARS-CoV-2 outbreak riskDavid R M Smith, Audrey Duval, Jean Ralph Zahar, et al.Antibiotics (Basel, Switzerland)|March 25, 2022
Empiric Treatment in HAP/VAP: "Don't You Want to Take a Leap of Faith?"Khalil Chaïbi, Gauthier Péan de Ponfilly, Laurent Dortet, et al.Microorganisms|April 3, 2021
Nosocomial Pneumonia in the Era of Multidrug-Resistance: Updates in Diagnosis and ManagementElena Xu, David Pérez-Torres, Paraskevi C Fragkou, et al.BMC Infectious Diseases|November 14, 2015
About the usefulness of contact precautions for carriers of extended-spectrum beta-lactamase-producing Escherichia coliJean-Ralph Zahar, Laurent Poirel, Claire Dupont, et al.Current Opinion in Investigational Drugs (London, England : 2000)|February 7, 2009
Addressing the challenge of extended-spectrum beta-lactamasesJean-Ralph Zahar, Olivier Lortholary, Claude Martin, et al.Pageof 17